FOCUS FINANCIAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Focus Financial Partners Inc. – FOCS
NEW ORLEANS, Jan. 26, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 4, 2024 to file lead plaintiff applications in a securities class action lawsuit against Focus Financial Partners Inc. (NasdaqGS: FOCS), if they (1) sold
FG GROUP HOLDINGS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of FG Group Holdings Inc. – FGH
NEW ORLEANS, Jan. 26, 2024 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of FG Group Holdings Inc. (NYSE: FGH) with FG Financial Group, Inc. (NasdaqGM: FGF
AMBRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. – AMAM
NEW ORLEANS, Jan. 26, 2024 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Ambrx Biopharma, Inc. (NasdaqGS: AMAM) to Johnson & Johnson (NYSE: JNJ). U
HOMOLOGY MEDICINES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. – FIXX
NEW ORLEANS, Jan. 26, 2024 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Homology Medicines, Inc. (NasdaqGS: FIXX) with Q32 Bio Inc. Under the terms of
L.A. Jury Awards $42.4 Million to Young Mother in Coma for Nearly Nine Years After Head-On Collision
LOS ANGELES, Jan. 26, 2024 /PRNewswire/ — A Lancaster jury yesterday awarded $42.4 million to a pregnant mother who has been in a coma ever since a head-on collision in 2015. With interest, the award will likely reach $55 million. Diana Estevez was a 23-year-old nursing student with a two-year
U.S. Holocaust Memorial Museum Marks International Holocaust Remembrance Day
WASHINGTON, Jan. 26, 2024 /PRNewswire/ — Holocaust survivors speak with visitors to the United States Holocaust Memorial Museum for International Holocaust Remembrance Day. International Holocaust Remembrance Day was established by the United Nations in 2005 to commemorate the six million Jewi
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, Jan. 26, 2024 /CNW/ – TSX VENTURE COMPANIES BULLETIN V2024-0284 ADVENTUS MINING CORPORATION (“ADZN”)LUMINEX RESOURCES CORP. (“LR”)BULLETIN TYPE: Plan of Arrangement, DelistBULLETIN DATE: January 26, 2024TSX Venture Tier 2 Companies TSX Venture Exchange In
Global Pompe Disease Drugs Market: USD 294.7 Million Growth Forecasted at a CAGR of 4.16% between 2024 to 2028 – Technavio
NEW YORK, Jan. 26, 2024 /PRNewswire/ — The Global Pompe Disease Drugs Market is to witness substantial growth, with a projected increase of USD 294.7 million at a Compound Annual Growth Rate (CAGR) of 4.16% between 2023 and 2028, as forecasted by Technavio. Pompe disease, characterized by aci
NASA Awards Contract for Aviation, Railroad Safety Reporting Systems
WASHINGTON, Jan. 26, 2024 /PRNewswire/ — NASA has awarded a contract to Booz Allen Hamilton Inc. of McLean, Virginia, for the maintenance and operation of incident reporting programs and continuing development to improve current and future reporting systems. The Aviation Safety Reporting Syst
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INSP
NEW YORK, Jan. 26, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important Febr
